{
    "1628092236586942475": {
        "attachments": {
            "media_keys": [
                "13_1628092187580694543"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-02-21T18:00:12.000Z",
        "edit_history_tweet_ids": [
            "1628092236586942475"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 14,
                    "normalized_text": "Prostate cancer",
                    "probability": 0.7387,
                    "start": 0,
                    "type": "Other"
                },
                {
                    "end": 229,
                    "normalized_text": "GU23",
                    "probability": 0.8456,
                    "start": 226,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 230,
                    "start": 225,
                    "tag": "GU23"
                }
            ],
            "urls": [
                {
                    "display_url": "pic.twitter.com/XQ9rJr05IA",
                    "end": 254,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1628092236586942475/video/1",
                    "media_key": "13_1628092187580694543",
                    "start": 231,
                    "url": "https://t.co/XQ9rJr05IA"
                }
            ]
        },
        "id": "1628092236586942475",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 4801,
            "like_count": 9,
            "quote_count": 1,
            "reply_count": 1,
            "retweet_count": 5
        },
        "text": "Prostate cancer that does not respond to hormone therapy is called castration-resistant and can spread, leading to worse outcomes. Knowing the symptoms can lead to rapid diagnosis and help ensure the best possible outcomes.\n\n#GU23 https://t.co/XQ9rJr05IA"
    }
}